Synonyms: BMY-28142 | BMY28142 | CFPM | Maxipime® | Renapime®
cefepime is an approved drug (FDA (1996), UK (2017))
Compound class:
Synthetic organic
Comment: Cefepime is a semisynthetic, broad-spectrum, fourth-generation cephalosporin antibacterial [1-2]. It was removed from the World Health Organization's List of Essential Medicines in 2019.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1996), UK (2017)) |
IUPAC Name |
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
International Nonproprietary Names | |
INN number | INN |
6092 | cefepime |
Synonyms |
BMY-28142 | BMY28142 | CFPM | Maxipime® | Renapime® |
Database Links | |
Specialist databases | |
Antibiotic DB | Cefepime + enmetazobactam (Exblifep) | Cefepime | Cefepime/VNRX-5133 |
Other databases | |
BindingDB Ligand | 50350470 |
CAS Registry No. | 88040-23-7 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL186 |
DrugCentral Ligand | 535 |
GtoPdb PubChem SID | 405560213 |
PubChem CID | 5479537 |
Search Google for chemical match using the InChIKey | HVFLCNVBZFFHBT-ZKDACBOMSA-N |
Search Google for chemicals with the same backbone | HVFLCNVBZFFHBT |
Search PubMed clinical trials | cefepime |
Search PubMed titles | cefepime |
Search PubMed titles/abstracts | cefepime |
UniChem Compound Search for chemical match using the InChIKey | HVFLCNVBZFFHBT-ZKDACBOMSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HVFLCNVBZFFHBT-ZKDACBOMSA-N |